Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 8, Number 6, June 2010

Free Content Platelet pharmacogenomics
pp. 1147-1158(12)
Authors: ZUERN, C. S.; SCHWAB, M.; GAWAZ, M.; GEISLER, T.

Favourites:
ADD

Free Content Hemostasis in Danio rerio: is the zebrafish a useful model for platelet research?
pp. 1159-1169(11)
Authors: LANG, M. R.; GIHR, G.; GAWAZ, M. P.; MÜLLER, I. I.

Favourites:
ADD

Free Content Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
pp. 1170-1175(6)
Authors: JONO, S.; OTSUKI, S.; HIGASHIKUNI, Y.; SHIOI, A.; MORI, K.; HARA, K.; HASHIMOTO, H.; IKARI, Y.

Favourites:
ADD

Free Content Prognostic value of the ankle-brachial index in elderly patients with a stable chronic cardiovascular event
pp. 1176-1184(9)
Authors: MANZANO, L.; MOSTAZA, J. M.; SUAREZ, C.; DEL VALLE, F. J.; ORTIZ, J. A.; SAMPEDRO, J. L.; POSE, A.; ROMAN, P.; VIEITEZ, P.; SÁNCHEZ-ZAMORANO, M. A.

Favourites:
ADD
Favourites:
ADD

Free Content Thrombophilia screening or screaming
pp. 1191-1192(2)
Author: KEELING, D.

Favourites:
ADD

Free Content A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin
pp. 1193-1200(8)
Authors: MAHMOODI, B. K.; BROUWER, J.-L. P.; TEN KATE, M. K.; LIJFERING, W. M.; VEEGER, N. J. G. M.; MULDER, A. B.; KLUIN-NELEMANS, H. C.; VAN DER MEER, J.

Favourites:
ADD

Free Content Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura
pp. 1201-1208(8)
Authors: MCDONALD, V.; MANNS, K.; MACKIE, I. J.; MACHIN, S. J.; SCULLY, M. A.

Favourites:
ADD

Free Content A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study
pp. 1209-1215(7)
Authors: RIESS, H.; HAAS, S.; TEBBE, U.; GERLACH, H.-E.; ABLETSHAUSER, C.; SIEDER, C.; ROSSOL, S.; PFEIFFER, B.; SCHELLONG, S. M.

Favourites:
ADD

Free Content Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry
pp. 1216-1222(7)
Authors: NIETO, J. A.; SOLANO, R.; RUIZ-RIBÓ, M. D.; RUIZ-GIMENEZ, N.; PRANDONI, P.; KEARON, C.; MONREAL, M.

Favourites:
ADD
Favourites:
ADD

Free Content Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems
pp. 1230-1234(5)
Authors: NENDAZ, M. R.; CHOPARD, P.; LOVIS, C.; KUCHER, N.; ASMIS, L. M.; DÖRFFLER, J.; SPIRK, D.; BOUNAMEAUX, H.

Favourites:
ADD

Free Content Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level
pp. 1235-1241(7)
Authors: AGTEROF, M. J.; SCHUTGENS, R. E. G.; SNIJDER, R. J.; EPPING, G.; PELTENBURG, H. G.; POSTHUMA, E. F. M.; HARDEMAN, J. A.; VAN DER GRIEND, R.; KOSTER, T.; PRINS, M. H.; BIESMA, D. H.

Favourites:
ADD

Free Content Validation of a clinical algorithm to identify low-risk patients with pulmonary embolism
pp. 1242-1247(6)
Authors: JAKOBSSON, C.; JIMÉNEZ, D.; GÓMEZ, V.; ZAMARRO, C.; MÉAN, M.; AUJESKY, D.

Favourites:
ADD

Free Content Perfusion defects after pulmonary embolism: risk factors and clinical significance
pp. 1248-1255(8)
Authors: SANCHEZ, O.; HELLEY, D.; COUCHON, S.; ROUX, A.; DELAVAL, A.; TRINQUART, L.; COLLIGNON, M.-A.; FISCHER, A.-M.; MEYER, G.

Favourites:
ADD

Free Content Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
pp. 1256-1265(10)
Authors: IORIO, A.; HALIMEH, S.; HOLZHAUER, S.; GOLDENBERG, N.; MARCHESINI, E.; MARCUCCI, M.; YOUNG, G.; BIDLINGMAIER, C.; BRANDAO, L. R.; ETTINGSHAUSEN, C. E.; GRINGERI, A.; KENET, G.; KNÖFLER, R.; KREUZ, W.; KURNIK, K.; MANNER, D.; SANTAGOSTINO, E.; MANNUCCI, P. M.; NOWAK-GÖTTL, U.

Favourites:
ADD
Favourites:
ADD

Free Content Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza
pp. 1273-1280(8)
Authors: GÉZSI, A.; BUDDE, U.; DEÁK, I.; NAGY, E.; MOHL, A.; SCHLAMMADINGER, Á.; BODA, Z.; MASSZI, T.; SADLER, J. E.; BODÓ, I.

Favourites:
ADD

Free Content Age-specific differences in binding of heparin to plasma proteins
pp. 1290-1294(5)
Authors: IGNJATOVIC, V.; STRAKA, E.; SUMMERHAYES, R.; MONAGLE, P.

Favourites:
ADD

Free Content Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner
pp. 1295-1301(7)
Authors: WHITE-ADAMS, T. C.; BERNY, M. A.; PATEL, I. A.; TUCKER, E. I.; GAILANI, D.; GRUBER, A.; MCCARTY, O. J. T.

Favourites:
ADD

Free Content Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor
pp. 1302-1312(11)
Authors: BUELENS, K.; HASSANZADEH-GHASSABEH, G.; MUYLDERMANS, S.; GILS, A.; DECLERCK, P. J.

Favourites:
ADD

Free Content Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets
pp. 1313-1322(10)
Authors: BAETEN, K. M.; RICHARD, M. C.; KANSE, S. M.; MUTCH, N. J.; DEGEN, J. L.; BOOTH, N. A.

Favourites:
ADD

Free Content Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells
pp. 1323-1332(10)
Authors: CARTER, J. C.; CAMPBELL, R. A.; GIBBONS, J. A.; GRAMLING, M. W.; WOLBERG, A. S.; CHURCH, F. C.

Favourites:
ADD

Free Content Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis
pp. 1333-1339(7)
Authors: LUCKING, A. J.; VISVANATHAN, A.; PHILIPPOU, H.; FRASER, S.; GRANT, P. J.; CONNOLLY, T. M.; GARDELL, S. J.; FEUERSTEIN, G. Z.; FOX, K. A. A.; BOOTH, N. A.; NEWBY, D. E.

Favourites:
ADD

Free Content Nitric oxide: a one-trick pony?
pp. 1340-1342(3)
Author: GORDGE, M. P.

Favourites:
ADD

Free Content Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition
pp. 1343-1352(10)
Authors: DANGEL, O.; MERGIA, E.; KARLISCH, K.; GRONEBERG, D.; KOESLING, D.; FRIEBE, A.

Favourites:
ADD

Free Content Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cγ2
pp. 1353-1363(11)
Authors: ELVERS, M.; POZGAJ, R.; PLEINES, I.; MAY, F.; KUIJPERS, M. J. E.; HEEMSKERK, J. M. W.; YU, P.; NIESWANDT, B.

Favourites:
ADD
Favourites:
ADD

Free Content Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
pp. 1372-1382(11)
Authors: GERNSHEIMER, T. B.; GEORGE, J. N.; ALEDORT, L. M.; TARANTINO, M. D.; SUNKARA, U.; MATTHEW GUO, D.; NICHOL, J. L.

Favourites:
ADD

Free Content Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase
pp. 1383-1393(11)
Authors: HUANG, Z. S.; ZENG, C. L.; ZHU, L. J.; JIANG, L.; LI, N.; HU, H.

Favourites:
ADD

Free Content Disturbed blood flow induces erosive injury to smooth muscle cell-rich neointima and promotes thrombus formation in rabbit femoral arteries
pp. 1394-1402(9)
Authors: SUMI, T.; YAMASHITA, A.; MATSUDA, S.; GOTO, S.; NISHIHIRA, K.; FURUKOJI, E.; SUGIMURA, H.; KAWAHARA, H.; IMAMURA, T.; KITAMURA, K.; TAMURA, S.; ASADA, Y.

Favourites:
ADD

Free Content Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms
pp. 1403-1409(7)
Authors: PATEL, K. N.; SOUBRA, S. H.; LAM, F. W.; RODRIGUEZ, M. A.; RUMBAUT, R. E.

Favourites:
ADD

Free Content Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease
pp. 1410-1412(3)
Authors: TRIPODI, A.; BAGLIN, T.; ROBERT, A.; KITCHEN, S.; LISMAN, T.; TROTTER, J. F.

Favourites:
ADD

Free Content Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study
pp. 1413-1416(4)
Authors: THOMSEN, R. W.; SCHOONEN, W. M.; FARKAS, D. K.; RIIS, A.; FRYZEK, J. P.; SØRENSEN, H. T.

Favourites:
ADD

Free Content Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder
pp. 1416-1419(4)
Authors: BISS, T. T.; BLANCHETTE, V. S.; CLARK, D. S.; WAKEFIELD, C. D.; JAMES, P. D.; RAND, M. L.

Favourites:
ADD

Free Content Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia
pp. 1419-1421(3)
Authors: REFAAI, M. A.; CHUANG, C.; MENEGUS, M.; BLUMBERG, N.; FRANCIS, C. W.

Favourites:
ADD

Free Content Clopidogrel and proton pump inhibitors: can near patient testing help in the tailoring of dual antiplatelet prescription?
pp. 1422-1424(3)
Authors: AMOAH, V.; WORRALL, A. P.; SMALLWOOD, A.; ARMESILLA, A. L.; NEVILL, A. M.; COTTON, J. M.

Favourites:
ADD

Free Content von Willebrand factor propeptide and the occurrence of a first ischemic stroke
pp. 1424-1426(3)
Authors: vanSCHIE, M. C.; DE MAAT, M. P.M.; DIPPEL, D. W.J.; deGROOT, P. G.; LENTING, P. J.; LEEBEEK, F. W. G.; HOLLESTELLE, M. J.

Favourites:
ADD

Free Content The effects of an extremely high dose of levothyroxine on coagulation and fibrinolysis
pp. 1427-1428(2)
Authors: STUIJVER, D. J. F; VAN ZAANE, B.; SQUIZZATO, A.; MEIJERS, J. C. M.; OTTEN, H. M.

Favourites:
ADD

Free Content Phosphatidylglycerol and daptomycin synergistically inhibit tissue factor-induced coagulation in the prothrombin time test
pp. 1429-1430(2)
Authors: VAN DEN BESSELAAR, A. M. H. P.; BREUKINK, E.; KOORENGEVEL, M. C.

Favourites:
ADD

Free Content Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD
pp. 1431-1433(3)
Authors: FLOOD, V. H.; LEDERMAN, C. A.; WREN, J. S.; CHRISTOPHERSON, P. A.; FRIEDMAN, K. D.; HOFFMANN, R. G.; MONTGOMERY, R. R.

Favourites:
ADD

Free Content Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?
pp. 1433-1435(3)
Authors: VUILLEUMIER, N.; LE GAL, G.; CORNILY, J. C.; HOCHSTRASSER, D.; BOUNAMEAUX, H.; AUJESKY, D.; RIGHINI, M.

Favourites:
ADD

Free Content Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal
pp. 1436-1437(2)
Authors: STÖLLBERGER, C.; FINSTERER, J.

Favourites:
ADD

Free Content Does dabigatran improve stroke-prevention in atrial fibrillation? Reply to a rebuttal
pp. 1438-1439(2)
Authors: EIKELBOOM, J. W.; WALLENTIN, L.; YUSUF, S.; EZEKOWITZ, M. D.; REILLY, P. A.; BRUECKMANN, M.; CLEMENS, A.; CONNOLLY, S. J.

Favourites:
ADD

Free Content Definition of major bleeding in surgery: an anesthesiologist’s point of view: a rebuttal
pp. 1442-1443(2)
Authors: ROSENCHER, N.; ZUFFEREY, P.; SAMAMA, C.-M.

Favourites:
ADD

Free Content Definition of major bleeding in surgery: an anesthesiologist’s point of view: reply to a rebuttal
pp. 1443-1444(2)
Authors: SCHULMAN, S.; ANGERÅS, U.; BERGQVIST, D.; ERIKSSON, B.; LASSEN, M. R.; FISHER, W.

Favourites:
ADD

Free Content Join ISTH
pp. 1445-1446(2)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more